Affordable Access

Toxicity of high-activity 111In-Octreotide therapy in patients with disseminated neuroendocrine tumours.

Authors
Type
Published Article
Journal
Nuclear Medicine Communications
0143-3636
Publisher
Ovid Technologies (Wolters Kluwer) - Lippincott Williams & Wilkins
Publication Date
Volume
21
Issue
1
Pages
97–102
Identifiers
PMID: 10717909
Source
Medline

Abstract

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments